David Chatenet

2.1k total citations
81 papers, 1.7k citations indexed

About

David Chatenet is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, David Chatenet has authored 81 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 32 papers in Molecular Biology and 32 papers in Pharmacology. Recurrent topics in David Chatenet's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (37 papers), Apelin-related biomedical research (30 papers) and Neuropeptides and Animal Physiology (25 papers). David Chatenet is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (37 papers), Apelin-related biomedical research (30 papers) and Neuropeptides and Animal Physiology (25 papers). David Chatenet collaborates with scholars based in Canada, France and Italy. David Chatenet's co-authors include Alain Fournier, Jérôme Leprince, Myriam Létourneau, Hubert Vaudry, David Vaudry, Hubert Vaudry, Elizabeth Scalbert, Hervé Tostivint, Terence E. Hébert and Christophe Dubessy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

David Chatenet

77 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chatenet Canada 25 829 641 595 463 456 81 1.7k
Tsukasa Sugo Japan 14 418 0.5× 317 0.5× 615 1.0× 212 0.5× 216 0.5× 20 1.3k
Anikó Váradi United Kingdom 25 921 1.1× 59 0.1× 1.3k 2.2× 291 0.6× 448 1.0× 43 2.3k
Ulla E. Petäjä‐Repo Finland 24 259 0.3× 116 0.2× 1.7k 2.9× 133 0.3× 883 1.9× 50 2.4k
Henry L. Puhl United States 22 99 0.1× 179 0.3× 1.0k 1.7× 77 0.2× 508 1.1× 54 1.6k
Vi Pham Australia 20 158 0.2× 94 0.1× 770 1.3× 111 0.2× 437 1.0× 39 1.3k
Sanne Møller Knudsen Denmark 11 222 0.3× 120 0.2× 930 1.6× 502 1.1× 430 0.9× 15 1.5k
Peidong Fan United States 20 76 0.1× 95 0.1× 1.2k 2.0× 60 0.1× 472 1.0× 33 2.0k
R.C. Davis United States 23 285 0.3× 39 0.1× 561 0.9× 348 0.8× 78 0.2× 31 1.4k
André Vandermeers Belgium 31 767 0.9× 99 0.2× 1.8k 3.0× 381 0.8× 1.7k 3.6× 104 2.8k
Balázs Szőke United States 19 83 0.1× 77 0.1× 631 1.1× 338 0.7× 421 0.9× 48 1.4k

Countries citing papers authored by David Chatenet

Since Specialization
Citations

This map shows the geographic impact of David Chatenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chatenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chatenet more than expected).

Fields of papers citing papers by David Chatenet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chatenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chatenet. The network helps show where David Chatenet may publish in the future.

Co-authorship network of co-authors of David Chatenet

This figure shows the co-authorship network connecting the top 25 collaborators of David Chatenet. A scholar is included among the top collaborators of David Chatenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chatenet. David Chatenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murza, Alexandre, Jérôme Côté, Jean‐Michel Longpré, et al.. (2025). Structure-activity relationships of contulakin-G: Design, synthesis, and characterization of Thr10 analogs for pain modulation. Biomedicine & Pharmacotherapy. 192. 118664–118664.
2.
Yamani, Lama, Julien Yockell‐Lelièvre, Terence E. Hébert, et al.. (2024). Enhanced Gαq Signaling in TSC2 -Deficient Cells Is Required for Their Neoplastic Behavior. American Journal of Respiratory Cell and Molecular Biology. 72(5). 578–590.
3.
Hébert, Terence E., et al.. (2023). Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics. Journal of Medicinal Chemistry. 66(20). 14241–14262. 3 indexed citations
4.
Chatenet, David, et al.. (2023). G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts. ACS Chemical Biology. 18(9). 2050–2062. 2 indexed citations
5.
Chatenet, David, et al.. (2022). The complicated lives of GPCRs in cardiac fibroblasts. American Journal of Physiology-Cell Physiology. 323(3). C813–C822. 6 indexed citations
6.
Merlino, Francesco, Ali Munaim Yousif, Salvatore Di Maro, et al.. (2019). Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides. Journal of Medicinal Chemistry. 62(3). 1455–1467. 21 indexed citations
7.
Létourneau, Myriam, et al.. (2019). The amidated PACAP1–23 fragment is a potent reduced-size neuroprotective agent. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(11). 129410–129410. 7 indexed citations
8.
Létourneau, Myriam, Dominic Devost, Terence E. Hébert, et al.. (2019). Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(11). 129398–129398. 8 indexed citations
9.
St‐Pierre, Yves, Nicolas Doucet, & David Chatenet. (2018). A New Approach to Inhibit Prototypic Galectins. Trends in Glycoscience and Glycotechnology. 30(172). SE155–SE165. 3 indexed citations
10.
Tadevosyan, Artavazd, Louis Villeneuve, Alain Fournier, et al.. (2015). Caged ligands to study the role of intracellular GPCRs. Methods. 92. 72–77. 13 indexed citations
11.
Chatenet, David, Steve Bourgault, & Alain Fournier. (2014). Design and Application of Light-Activated Probes for Cellular Signaling. Methods in molecular biology. 1234. 17–30. 2 indexed citations
12.
Vaudry, Hubert, Jérôme Leprince, David Chatenet, et al.. (2014). International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function. Pharmacological Reviews. 67(1). 214–258. 78 indexed citations
13.
Vaniotis, George, Clémence Merlen, C. Daniel Smith, et al.. (2013). Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors. Journal of Molecular and Cellular Cardiology. 62. 58–68. 42 indexed citations
14.
Doan, Ngoc‐Duc, David Chatenet, Myriam Létourneau, et al.. (2012). Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(4). 940–949. 27 indexed citations
15.
Chatenet, David, et al.. (2011). Urocontrin, a novel UT receptor ligand with a unique pharmacological profile. Biochemical Pharmacology. 83(5). 608–615. 24 indexed citations
16.
Fu, Yan, Myriam Létourneau, Quang T. Nguyen, et al.. (2009). Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. European Journal of Pharmacology. 617(1-3). 118–123. 8 indexed citations
17.
Bruzzone, Federica, Benoît Lectez, David Alexandre, et al.. (2007). Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. The Journal of Comparative Neurology. 503(4). 573–591. 68 indexed citations
18.
Jégou, Sylvie, Dorthe Cartier, Christophe Dubessy, et al.. (2006). Localization of the urotensin II receptor in the rat central nervous system. The Journal of Comparative Neurology. 495(1). 21–36. 56 indexed citations
19.
do-Rego, Jean-Claude, David Chatenet, Jérôme Leprince, et al.. (2005). Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology. 183(1). 103–117. 47 indexed citations
20.
Chartrel, Nicolas, et al.. (2004). Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. Journal of Neurochemistry. 91(1). 110–118. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsukasa Sugo Breakdown of academic impact, for papers by Anikó Váradi Breakdown of academic impact, for papers by Ulla E. Petäjä‐Repo Breakdown of academic impact, for papers by Henry L. Puhl Breakdown of academic impact, for papers by Vi Pham Breakdown of academic impact, for papers by Sanne Møller Knudsen Breakdown of academic impact, for papers by Peidong Fan Breakdown of academic impact, for papers by R.C. Davis Breakdown of academic impact, for papers by André Vandermeers Breakdown of academic impact, for papers by Balázs Szőke
Rankless by CCL
2026